Fontolizumab

Source: Wikipedia, the free encyclopedia.
Fontolizumab
Humanized (from mouse)
Targetinterferon gamma
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
Molar massca. 150 kg/mol
 ☒NcheckY (what is this?)  (verify)

Fontolizumab (planned trade name HuZAF) is a

auto-immune diseases like Crohn's disease.[2] A phase II clinical trial investigating the use for rheumatoid arthritis was terminated because the first phase did not meet the endpoint.[3]

References

  1. ^ Statement On A Nonproprietary Name Adopted By The Usan Council - Fontolizumab, American Medical Association.
  2. S2CID 25337474
    .
  3. ^ Clinical trial number NCT00281294 for "A Phase 2 Study to Evaluate the Safety, Tolerability, and Activity of Fontolizumab in Subjects With Active Rheumatoid Arthritis" at ClinicalTrials.gov
Retrieved from "https://en.wikipedia.org/w/index.php?title=Fontolizumab&oldid=1170236054"